News - Page 4 of 13 - Leukaemia Care

10th July 2023

Scottish Medicines Consortium (SMC) decides not to approve treatment for PV patients in Scotland

The SMC has decided not to approve Besremi, also known as ropeginterferon alfa-2b, for use on the NHS in Scotland. This treatment is a monotherapy, intended to treat adult patients with polycythaemia vera (PV), without symptoms of an enlarged spleen.

19th June 2023

Scottish Government publishes their Cancer Strategy for Scotland 2023-2033

The Cancer Strategy for Scotland 2023-33 sets out the Scottish Government’s aims for ensuring patients receive the best treatment and support throughout their cancer journey, and improving outcomes and survival for cancer patients.

12th June 2023

Leukaemia Care successfully campaigns for equal access in Scotland to a new stem cell transplant conditioning treatment for leukaemia patients

Leukaemia Care has successfully campaigned for the Scottish Medicine Consortium (SMC) to approve treosulfan (Trecondi) in combination with fludarabine in Scotland as a conditioning treatment for patients prior to receiving an allogeneic haematopoietic stem cell transplant (alloHSCT).

19th May 2023

Leukaemia Care publish open letter to UK governments

Leukaemia Care have published an open letter to the Prime Minister, and First Ministers of Scotland, Wales, and Northern Ireland, urging them to provide more support for CLL patients on Watch and Wait

5th May 2023

A final decision on Evusheld announced by the National Institute of Health and Care Excellence (NICE)

This blog explains the latest updates from the National Institute for Health and Care Excellence (NICE) on their review of Evusheld, a COVID-19 preventative treatment.

27th April 2023

Leukaemia Care campaigns for provisional access to a potentially curative treatment for adult ALL patients

The National Institute for Health and Care Excellence (NICE) is set to approve CAR-T therapy provisionally on the NHS in England for all suitable adults over 25 with acute lymphoblastic leukaemia (ALL).

21st April 2023

Leukaemia Care successfully campaigns for new leukaemia treatment on behalf of CLL patients

Today the National Institute for Health and Care Excellence (NICE) announces the approval of ibrutinib in combination with venetoclax on the NHS in England for patients with chronic lymphocytic leukaemia (CLL).

3rd April 2023

Leukaemia Care and Leukaemia UK relaunch financial support service in response to the ongoing cost of living

Leukaemia Care and Leukaemia UK have relaunched their Cost of Living Fund in response to the ongoing cost of living crisis in the UK to help support leukaemia, MDS and MPN patients.

15th March 2023

Leukaemia Care joins Martin Lewis in successfully campaigning for the energy price guarantee hike to be postponed

Leukaemia Care proudly joined Martin Lewis and MoneySavingExpert in calling on the Chancellor to postpone the energy price hikes, rather than increasing them from 1 April 2023 as planned.

14th March 2023

We’re taking our campaign to Holyrood, Edinburgh

At Leukaemia Care, we have been campaigning for better financial support for leukaemia, MDS and MPN patients and their families. The next step in our campaign involves going to Downing Street so that our voices are heard by the decision makers.